Caxton Corp as of June 30, 2022
Portfolio Holdings for Caxton Corp
Caxton Corp holds 16 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| United Sts Oil Units Call Option (USO) | 38.2 | $28M | 354k | 80.35 | |
| Savara (SVRA) | 14.1 | $11M | 6.9M | 1.52 | |
| Xeris Pharmaceuticals (XERS) | 12.5 | $9.3M | 6.0M | 1.54 | |
| Spdr Gold Tr Gold Shs (GLD) | 9.2 | $6.9M | 41k | 168.47 | |
| Spdr S&p 500 Etf Tr Tr Unit (SPY) | 8.1 | $6.0M | 16k | 377.25 | |
| Rezolute Com New (RZLT) | 6.1 | $4.5M | 1.4M | 3.23 | |
| Scynexis Com New (SCYX) | 4.3 | $3.2M | 1.7M | 1.86 | |
| Molecular Templates | 2.5 | $1.9M | 2.1M | 0.91 | |
| Arcellx Common Stock (ACLX) | 2.5 | $1.8M | 102k | 18.08 | |
| Vectivbio Hldg Ord Shs | 1.4 | $1.1M | 195k | 5.40 | |
| Eiger Biopharmaceuticals | 1.0 | $736k | 117k | 6.30 | |
| Elevation Oncology (ELEV) | 0.1 | $96k | 68k | 1.41 | |
| Bridgetown Holdings *w Exp 09/30/202 | 0.0 | $10k | 40k | 0.25 | |
| Lux Health Tech Acquisition *w Exp 11/30/202 | 0.0 | $9.0k | 67k | 0.14 | |
| Frazier Lifesciences Acqu *w Exp 11/30/202 | 0.0 | $2.0k | 21k | 0.09 | |
| Primavera Capital Acquist *w Exp 01/19/202 | 0.0 | $2.0k | 12k | 0.17 |
